LPCN
LipocineANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
LPCN vs peer average
95/100
LPCN vs. peer average (A vs. D)
Grade spread
A 1 · B 1 · C 1 · D 2 · F 6
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
INMB is the first available peer comparator.
INmune Bio is another development-stage biotech where data releases and capital-market windows drive sentiment; the read-across is mainly around dilution sensitivity and low-visibility pipeline optionality.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
LPCN
Lipocine
INMB
INmune Bio
Grade
A
F
Momentum
100
16
Value
42
41
Sentiment
45
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs INMB
LPCN / INMB
Grade Position
Above peers
LPCN vs. peer average (A vs. D)
95/100
Momentum
100
LPCNValue
42
LPCNSentiment
45
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs LPCN
INMB is the first peer returned for this comparison set.